Article
Mutation of Beclin1 acetylation site at K414 alleviates high glucose-induced podocyte impairment in the early stage of diabetic nephropathy by inhibiting hyperactivated autophagy.
Molecular biology reports - 1 May 2022
Xu Jun, Deng Yujie, Ke Yingying, Zhu Yunxia, Wang Ping, Yu Qing, Li Chengqian, Shi Bimin
Abstract excerpt
BACKGROUND: Our group recently reported that a mutation of the novel Beclin1 K414R acetylation site impacts the stability of Beclin1 protein, which decreases autophagy in adipocytes and further impedes adipocyte differentiation and lipolysis. This study was to explore whether Beclin1 acetylation plays a role in the early renal injury induced by high glucose and to further investigate the K414R mutation site in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
